Publications
- Ocrelizumab - long-term efficacy and safety in real-world clinical practice in patients with relapsing-remitting multiple sclerosis2022 | Second Faculty of Medicine
- Management of secondary-progressive multiple sclerosis2022 | Second Faculty of Medicine
- Profile of a patient with secondary progressive MS - how to identify patients that should be sent to a tertiary Center2021 | Second Faculty of Medicine
- Ofatumumab - new and different monoclonal anti-CD20 antibody in the treatment of multiple sclerosis2021 | Second Faculty of Medicine
- Effectiveness of natalizumab extended interval dosing in multiple sclerosis patients2020 | Second Faculty of Medicine
- Autoimmune encephalitis with negative anti-neuronal antibodies - clinical characteristics and available methods of antibody detection2020 | Second Faculty of Medicine
- Anti-NMDAR Antibodies in Demyelinating Diseases2017 | Second Faculty of Medicine, Third Faculty of Medicine
- Autoimmune Encephalitis2015 | Central Library of Charles University, Second Faculty of Medicine
- When to consider autoimmune etiology of central nervous system disorders in clinical practice2015 | Second Faculty of Medicine
- Low prevalence of neural autoantibodies in perioperative cerebrospinal fluid samples of epilepsy surgery patients: A multicenter prospective study2024 | Central Library of Charles University, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
Loading network view...
